COVID-19 vaccination outcomes among patients with dermatomyositis: a multicentered analysis
Clin Rheumatol
.
2022 Jul;41(7):2257-2260.
doi: 10.1007/s10067-022-06081-7.
Epub 2022 Jan 27.
Authors
Haig Pakhchanian
#
1
,
Ahmad Saud
#
2
,
Rahul Raiker
3
,
Sinan Kardes
4
,
Rohit Aggarwal
5
,
Latika Gupta
6
Affiliations
1
George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
2
Department of Medicine, Royal College of Surgeons Ireland, Dublin, Ireland.
3
West Virginia University School of Medicine, Morgantown, WV, USA.
4
Department of Medical Ecology and Hydroclimatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
5
Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
6
Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, WV10 0QP, UK.
[email protected]
.
#
Contributed equally.
PMID:
35084602
PMCID:
PMC8792517
DOI:
10.1007/s10067-022-06081-7
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines
COVID-19* / prevention & control
Dermatomyositis* / complications
Humans
Vaccination / adverse effects
Substances
COVID-19 Vaccines